eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
1/2002
vol. 1
 
Share:
Send email
Share:
abstract:

Role of hormone replacement therapy in treatment of women with chronic renal failure – potential benefits and hazards

Beata Kos-Kudła
,
Bogdan Marek
,
Dariusz Kajdaniuk
,
Paweł Staszewicz
,
Zofia Ostrowska

(Prz Menopauz 2002; 1: 46–52)
Online publish date: 2004/03/03
View full text Get citation
 
Patients with chronic renal failure (CRF) show an excess mortality from cardiovascular disease. In patients with CRF there have been identified many risk factors for cardiovascular diseases including estrogen deficiency which can manifest in women with CRF as premature menopause and it is associated with high risk not only for cardiovascular complications but for renal osteodystrophy as well. It is now well established that hormone replacement therapy (HRT) has beneficial effects on various atherosclerotic parameters in population of postmenopausal women and its role in primary prevention of coronary artery disease has been reported in many studies. There is still a question of debate if advanteges of HRT reported in studies based on general population of postmenopausal women can also be observed in women with CRF and estrogen deficiency.
keywords:

chronic renal failure, hormonal replacement therapy, estradiol, cardiovascular complications
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.